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We present the first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder (BPAD),
using a large linkage data set (52 families of European descent; 448 participants and 259 affected individuals). Our results
provide the strongest interaction evidence between BPAD genes on chromosomes 2q22-q24 and 6q23-q24, which was
observed symmetrically in both directions (nonparametric LOD [NPL] scores of 7.55 on 2q and 7.63 on 6q; P ! .0001
and , respectively, after a genomewide permutation procedure). The second-best BPAD interaction evidencePp .0001
was observed between chromosomes 2q22-q24 and 15q26. Here, we also observed a symmetrical interaction (NPL scores
of 6.26 on 2q and 4.59 on 15q; and .0022, respectively). We covered the implicated regions by genotypingPp .0057
additional marker sets and performed a detailed interaction linkage analysis, which narrowed the susceptibility intervals.
Although the heterogeneity analysis produced less impressive results (highest NPL score of 3.32) and a less consistent
picture, we achieved evidence of locus heterogeneity at chromosomes 2q, 6p, 11p, 13q, and 22q, which was supported
by adjacent markers within each region and by previously reported BPAD linkage findings. Our results provide systematic
insights in the framework of BPAD epistasis and locus heterogeneity, which should facilitate gene identification by the
use of more-comprehensive cloning strategies.
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Bipolar affective disorder (BPAD [MIM 125480]) is char-
acterized by severe episodes of mania and depression
and represents a common disorder affecting ∼1% of the
world’s population. Therefore, BPAD is considered to be
one of the top public health problems associated with a
significant morbidity (World Health Organization, World
Health Report 2002). Although formal genetic studies con-
sistently provide strong evidence of a major genetic con-
tribution to BPAD,1 the underlying genetic architecture is
poorly understood. The pattern of inheritance is complex,
reflecting the actions and interactions of multiple genetic
and environmental factors, which has led to difficulties
in mapping individual risk genes by conventional linkage
studies. Although some promising loci have been identi-
fied in BPAD by genomewide linkage studies (reviewed in
the work of Craddock and Forty2), the overall linkage pic-
ture is characterized by failures to replicate even the most
interesting loci indicated by individual studies, and levels
of statistical linkage significance point to more-modest
effects for each single locus. Even in the most extensive
and detailed linkage meta-analysis performed by Segurado
et al.,3 no genomewide significant linkage evidence was
observed.
Here, we present a systematic approach that allows for
a genomewide consideration of susceptibility from mul-
tiple loci and may therefore improve the ability to map
genes for BPAD. We used a large BPAD linkage data set
and performed a genomewide interaction linkage scan.
The families represent the same data set with which we
previously performed a one-dimensional linkage analysis.4
To estimate the overall significance of the genomewide
interaction findings, we performed a permutation pro-
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Table 1. Characteristics of the BPAD
Sample Studied for the Genomewide
Interaction Scan
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
cedure, analyzing 10,000 replicates. The BPAD regions
showing the strongest interaction evidence were subse-
quently covered by genotyping additional sets of linkage
markers. This step was performed to narrow the suscep-
tibility intervals. In addition, we performed a genomewide
locus-heterogeneity analysis to identify BPAD loci in fam-
ilies that show negative linkage evidence at a conditional
marker. In particular, we were interested in the pattern of
locus heterogeneity within the identified BPAD-interac-
tion regions.
Material and Methods
Subjects
The genomewide interaction scan was performed with 52 families
with Spanish, Bulgarian, and Romany descent, consisting of 448
subjects, of whom 259 were affected. Informed consent was ob-
tained from all participants. The study complied with all ethical
guidelines of the institutions involved. A description of the family
structure is presented in table 1. The ascertainment scheme is
given in detail in the work of Schumacher et al.4 In brief, the
phenotype evaluation was based on DSM-IV criteria.5 The inclu-
sion criteria for families with BPAD were the presence of a pro-
band with bipolar I (BP I) disorder and a secondary affected sibling
with either BP I, bipolar II (BP II), schizoaffective disorder bipolar
type (SA/BP), or unipolar recurrent depression (UPR). Given com-
putational constraints, and to reduce the number of statistical
tests, the families were not divided into subsamples and were not
analyzed separately according to their regional descent. For the
same reason, the analysis was restricted to the broad affection
status definition (BP I, BP II, SA/BP, and UPR), which included
the maximum number of affected individuals and produced the
strongest linkage evidence within our one-dimensional scan.4
Genotyping
The genotyping for the genomewide analysis was conducted at
the Gene Mapping Center in Berlin (procedures described in the
work of Lee et al.6). A total of 435 STR markers were genotyped,
with an average intermarker distance of 8.3 cM (deCODE Genetics
map). The additional linkage markers, which covered the inter-
acting BPAD regions, were genotyped at deCODE Genetics in
Reykjavik (21 markers on chromosome 6q23-q24, with the use
of procedures described in the work of Bjornsson et al.7) and at
the Institute of Human Genetics in Bonn (21 markers on chro-
mosomes 2q21-q24 and 15q26, with the use of procedures de-
scribed in the work of Cichon et al.8).
Statistical Analysis
The multipoint nonparametric interaction analysis was per-
formed according to the method described by Kong and Cox,9
with the use of proportional family weights (weightPROP), in ac-
cordance with the work of Cox et al.10 In detail, for each family,
multimarker NPL scores were calculated under the given trait
definition at each genomewide linkage marker. The NPL score of
a given family at a given marker locus called the “conditional
marker” was then used as a weighting factor (weightPROP) for the
same family, and a multipoint NPL analysis at a second marker
locus called the “scan marker” was performed. Only families with
NPL scores 10 at the conditional locus were included for the in-
teraction linkage analyses at the scan markers. Thus, the weight-
ing factors used were proportional to the linkage evidence at the
conditional locus. At each scan marker of the genome, two NPL
scores were determined: one unweighted, called the “baseline
NPL score,” and one under the weighting scheme, called the “in-
teraction NPL score.” The difference between these two NPL
scores is termed “DNPL score.” The weighting scheme corre-
sponds to the scheme called “PROP” by Cox et al.,10 except for
a slight modification: if the baseline NPL score was !0, it was set
to 0 before calculating the difference. This avoids positive DNPL
scores in a region with negative NPL scores and, thus, negative
linkage evidence. Furthermore, DNPL scores were calculated only
if interaction NPL scores were greater than baseline NPL scores.
For the multipoint nonparametric locus-heterogeneity analysis,
we adapted the linkage approach described above, with the ex-
ception of using another weighting scheme: at the conditional
locus, only families with NPL scores !0 were included, and, for
the heterogeneity linkage analysis at the scan locus, weighting
factors were used that were inversely proportional to the negative
NPL scores at the conditional locus. In correspondence with the
procedure described above, we determined two NPL scores at the
scan locus: one unweighted baseline NPL score and one under
the weighing scheme, called the “heterogeneity NPL score.” The
difference between both NPL scores was again termed “DNPL
score.” The baseline NPL score was set to 0 if it was !0, and, as
described above, DNPL scores were calculated only if heteroge-
neity NPL scores were greater than baseline NPL scores. Both the
genomewide interaction and locus-heterogeneity analyses were
restricted to interchromosomal markers, to avoid statistical in-
terference. Both analyses were done by running Allegro version
2.0f.11
To assess the significance of our genomewide interaction and
locus-heterogeneity findings, we performed genomewide per-
mutation analyses. We randomly permuted the family weights
for all conditional markers simultaneously on the same chro-
mosome to assess their contributions to the interaction and het-
erogeneity NPL scores. Since DNPL scores reflect the differences
between the baseline and the interaction/heterogeneity NPL
scores, the exceeding probabilities determined by the permuta-
tion procedure refer to the P values for both DNPL scores and
interaction/heterogeneity NPL scores. The permutation was ap-
plied to all conditional- and scan-marker combinations only in
the case where both were located on separate chromosomes. For
each combination, 10,000 permutations were done, and, for each
combination, the permutation was followed by calculating the
interaction and heterogeneity NPL scores under each weight. Per-
mutation-based NPL scores that exceeded those from the original
weighting procedure were counted and were then used to deter-
mine the significance of the findings. Permutation analyses were
performed by using a dedicated program, which took 193 h for
each weighting scheme (interaction and heterogeneity).
To enable the research community to implement all statistical
methods, we created a Web site that includes all programs used
in the present study (see the Institute for Medical Biometry Web
site). In addition, the genotypic and phenotypic information
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Table 2. Top 100 Genomewide Interaction
DNPL Scores in BPAD, Ordered according to
the Conditional Chromosomes
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 1. Genomewide interaction scan for BPAD. The different levels of DNPL scores are presented using different colors: red indicates
DNPL scores 14; yellow indicates DNPL scores 13; green indicates DNPL scores 12; light blue indicates DNPL scores 11; dark blue
indicates DNPL scores 10; black indicates DNPL scores !0.
from our genome scan and fine-mapping data set can be obtained
on request.
Results
Genomewide Interaction Scan
Figure 1 presents the data from our genomewide inter-
action scan. Table 2 lists the top 100 genomewide DNPL
scores, and table 3 presents the top 10 DNPL results.
Only two findings—between chromosomes 2q and 6q
as well as 2q and 15q—belonged to the top 10 genome-
wide BPAD interactions and produced DNPL scores 15
(table 3 and fig. 1). On chromosome 2q22-q24, four adja-
cent markers showed DNPL scores 16 with use of a con-
ditional STR on 6q23. Within the center of this region,
we observed the strongest interaction, with a DNPL score
of 6.94, at D2S1399 and an interaction NPL score of 7.55
at D2S2241 (table 3). This interaction is supported by the
genomewide permutation procedure. P values between
!.0001 and .0014 were observed for all implicated 2q
markers (table 3). In addition, our analysis provided
strong interaction evidence on chromosome 6q23 (DNPL
scores 14) by the use of conditional markers on 2q22-q24
(fig. 1 and table 2). One of these findings belongs to the
top 10 genomewide interaction results. At D6S1009, we
observed a DNPL score of 4.96 and an interaction NPL
score of 7.63 (table 3). This vice-versa interaction was ob-
served only once by chance through 10,000 permutations
( ) (table 3). The second BPAD interaction withPp .0001
DNPL scores belonging to the top 10 genomewide results
was observed between 15q26 and, again, chromosome
2q22-q24 (table 3 and fig. 1). With use of D15S642 as the
conditional marker, three adjacent STRs on chromosome
2q showed DNPL scores 15. The strongest interaction was
observed at D2S1399, with a DNPL score of 5.65 (table 3).
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Table 3. Genomewide Top 10 DNPL Scores in BPAD, Ordered according to Interacting Regions
Rank
Conditional Marker Scan Marker
PbChromosome Marker Positiona Chromosome Marker Positiona
Baseline
NPL
Interaction
NPL DNPL
1 6 D6S1009 138.76 2 D2S1399 158.20 .38 7.32 6.94 .0001
2 6 D6S1009 138.76 2 D2S2241 163.27 1.06 7.55 6.48 !.0001
3 6 D6S1009 138.76 2 D2S1334 148.76 .75 6.94 6.20 .0005
4 6 D6S1009 138.76 2 D2S1353 167.91 .23 6.24 6.01 .0008
5 6 D6S1009 138.76 2 D2S114 146.86 .67 6.57 5.89 .0014
9 2 D2S2241 163.27 6 D6S1009 138.76 2.67 7.63 4.96 .0001
6 15 D15S642 133.69 2 D2S1399 158.20 .38 6.03 5.65 .0061
7 15 D15S642 133.69 2 D2S1353 167.91 .23 5.72 5.50 .0044
8 15 D15S642 133.69 2 D2S2241 163.27 1.06 6.26 5.20 .0057
10 15 D15S642 133.69 2 D2S1334 148.76 .75 5.67 4.92 .0127
NOTE.—For each scan marker, the DNPL and interaction NPL scores are presented. In addition, the baseline NPL score observed in the one-
dimensional genomewide scan is presented.
a Determined from the deCODE Genetics sex-averaged map.
b P values are determined through 10,000 genomewide permutations.
Table 4. Fine-Mapping Linkage Markers
Ordered according to Their Interacting
Regions
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
The genomewide permutation showed that one would ex-
pect this interaction in 61 of 10,000 replicates by chance
( ) (table 3). The highest interaction NPL scorePp .0061
of 6.26 was observed at D2S2241 (table 3). Although none
of the 15q markers showed DNPL scores belonging to the
top 10 interaction results, there was some evidence of epis-
tasis in both directions. By use of 2q STRs as conditional
markers, DNPL scores 13 were observed on chromosome
15q26 (best DNPL score of 3.92 at D15S642, rank 38,
) (table 2).Pp .0022
Detailed Interaction Linkage Analysis on Chromosomes
2q22-q24 and 6q23-q24
In addition to the genomewide scan markers, 15 further
STR markers on chromosome 2q (interval D2S347–D2S376,
average intermarker distance 2.06 cM) and 21 further STRs
on chromosome 6q were genotyped (interval D6S407–
D6S494, average intermarker distance 1.21 cM) (table 4).
The most centromeric and telomeric markers were located
at a distance of 110 cM from the STRs, which showed
DNPL scores within the genomewide top 10 range. On
chromosome 2q, 113 marker combinations showed DNPL
scores 15 with use of conditional STRs on 6q. The 10 best
DNPL findings—scores between 5.97 and 6.69—are pre-
sented in table 5 and were observed at four adjacent
markers (table 5 and fig. 2A). The strongest interaction
NPL score of 6.70 was observed at D2S222 (table 5). In the
vice-versa direction, a total of 133 marker combinations
showed DNPL scores 14 on chromosome 6q. The 10 best
DNPL findings—scores between 4.67 and 4.84—are lo-
cated in the same region as those found when chromo-
some 6 STRs were used as conditional markers for the
chromosome 2q scan (table 5 and fig. 2B). The strongest
interaction NPL score of 7.66 was observed at D6S403 (ta-
ble 5).
The robustness of our finding is implicated not only by
the permutation analysis but also by the fact that a high
proportion of the families contributes to the interaction.
With use of STRs on 6q23-q24 as conditional markers,
∼69% ( ) of the 52 families contributed to the in-np 36
teraction on 2q, and ∼36% ( ) were thereby attrib-np 19
uted with a weightPROP factor 11, indicating that their link-
age contribution to the interaction findings increased by
a factor 11 compared with the baseline study (factorp
) (fig. 3A and 3B). Similarly, a majority, ∼61% ( ),1 np 32
of families contributed to the interaction on 6q with use
of conditional markers at 2q22-q24, and ∼36% ( )np 19
were attributed with a weightPROP factor 11 (fig. 3A and
3B). The symmetry of our finding is also indicated by the
distribution of families contributing to the vice-versa in-
teraction: ∼42% ( ) of families were included in thenp 22
study through their overlapping linkage evidence at con-
ditional loci 2q and 6q, and ∼21% ( ) were therebynp 11
attributed with a weightPROP factor 11 (fig. 3A and 3B).
Detailed Interaction Linkage Analysis on Chromosomes
2q22-q24 and 15q26
The second-best BPAD interaction was observed between
chromosomes 2q22-q24 and 15q26. Whereas the 2q re-
gion was already covered by 21 STR markers for the 6q
fine mapping, 6 additional markers were genotyped on
the 15q26 (interval D15S130–STR15-1002, average inter-
marker distance 2.83 cM) (table 4). Since D15S642—which
showed the strongest genomewide interaction—is located
only 0.18 Mb from the telomeric end of chromosome 15,
little information about additional STRs within this region
is available in public databases. We therefore performed a
marker discovery analysis, using the tandem repeat finder
program by Benson et al.,12 and identified three hitherto
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Table 5. DNPL Scores for the BPAD Interaction between Chromosome 2q22-q24 and
6q23-q24
Chromosome
and Rank
Conditional Marker Scan Marker
Marker Positiona Marker Positiona
Baseline
NPL
Interaction
NPL DNPL
2q22-q24:
1 D6S1009 138.76 D2S1399 158.20 .04 6.69 6.69
2 D6S1587 141.16 D2S1399 158.20 .04 6.69 6.69
3 D6S1009 138.76 D2S381 157.19 .03 6.67 6.67
4 D6S1009 138.76 D2S222 158.35 .06 6.70 6.64
5 D6S1587 141.16 D2S381 157.19 .03 6.63 6.63
6 D6S1587 141.16 D2S222 158.35 .06 6.69 6.63
7 D6S1626 136.31 D2S1399 158.20 .04 6.09 6.09
8 D6S1626 136.31 D2S381 157.19 .03 6.07 6.07
9 D6S1626 136.31 D2S222 158.35 .06 6.10 6.03
10 D6S1009 138.76 D2S2275 161.36 .84 6.81 5.97
6q23-q24:
1 D2S1353 167.91 D6S1587 141.16 2.67 7.51 4.84
2 D2S1353 167.91 D6S403 143.66 2.91 7.66 4.79
3 D2S1353 167.91 D6S1699 143.59 2.89 7.64 4.74
4 D2S321 163.27 D6S1587 141.16 2.67 7.39 4.72
5 D2S2241 163.27 D6S1587 141.16 2.67 7.39 4.72
6 D2S381 157.19 D6S1587 141.16 2.67 7.38 4.71
7 D2S1353 167.91 D6S1009 138.76 2.85 7.55 4.70
8 D2S1399 158.20 D6S1587 141.16 2.67 7.36 4.69
9 D2S222 158.19 D6S1587 141.16 2.67 7.34 4.67
10 D2S2950 165.18 D6S976 133.57 2.70 7.37 4.67
NOTE.—The first set of 10 rankings represents the strongest DNPL and interaction NPL scores on chro-
mosome 2q22-q24 with the use of STRs on 6q as conditional markers. The second set of 10 rankings
represents the strongest DNPL and interaction NPL scores on chromosome 6q23-q24 with the use of STRs
on 2q as conditional markers. In addition, for each scan marker, the baseline NPL score is presented.
a Determined from the deCODE Genetics sex-averaged map.
unknown markers (STR15-980, STR15-994, and STR15-
1002), which were analyzed together with three anno-
tated markers. The most centromeric marker (D15S130)
was located at a distance of 110 cM from D15S642. On
chromosome 2q, we observed at 11 marker combinations
DNPL scores 15, using conditional STRs on 15q. The 10
best DNPL findings—scores between 5.08 and 5.62—were
found in a circumscribed region with use of two adjacent
15q conditional markers (table 6 and fig. 4A). The stron-
gest interaction NPL score of 6.00 was observed for
D2S2950 (table 6). In the vice-versa direction, a total of
23 marker combinations showed DNPL scores 13 on chro-
mosome 15q. The same two STRs that produced the stron-
gest interaction evidence when used as conditional mark-
ers for the 2q scan were implicated by the top 10 DNPL
findings on chromosome 15q (scores between 3.40 and
3.74) (table 6 and fig. 4A). The strongest interaction NPL
score on 15q26 was 3.86 and is located at D15S642 (table
6).
Although less impressive when compared with the
BPAD interaction between 2q and 6q, the interaction be-
tween 2q and 15q was observed in a substantial propor-
tion of families. With use of STRs on 15q26 as conditional
markers, ∼59% ( ) of families contributed to the in-np 31
teraction on 2q, and ∼21% ( ) were thereby attrib-np 11
uted with a weightPROP factor 11 (fig. 3C and 3D). With
use of conditional markers at 2q22-q24, ∼61% of fam-
ilies contributed to the interaction on 15q, and ∼36%
were attributed with a weightPROP factor 11 (fig. 3C and
3D). Furthermore, fewer families than those in the 2q-
6q interaction contributed symmetrically to the epista-
sis between 2q and 15q: ∼32% ( ) of familiesnp 17
were included in the study because of their overlapping
linkage evidence at both loci, and a moderate number,
∼13% ( ), of families were thereby attributed with anp 7
weightPROP factor 11 (fig. 3C and 3D).
Genomewide Locus-Heterogeneity Scan
In addition to the identification of interacting BPAD loci,
we were interested in the pattern of locus heterogeneity
in our family data set. Therefore, we performed a ge-
nomewide locus-heterogeneity analysis. Those BPAD-af-
fected families that showed negative linkage evidence at
each conditional marker were assigned a weight propor-
tional to the absolute value of the NPL score. Table 7 lists
the top 10 heterogeneity findings, representing the DNPL
scores 12.5 (see table 8 for the top 100 heterogeneity find-
ings). The reason for these rather moderate linkage find-
ings and the fact that they were assessed as significant by
our permutation procedure (see table 7) can be explained
by the small proportion of contributing families. Although
many families ( –26) were included in the analysisnp 24
of the top 10 heterogeneity results with a weightPROP factor
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Figure 2. Three-dimensional DNPL plot for the BPAD interaction between chromosomes 2q22-q24 and 6q23-q24. The 1-LOD intervals
are given at the bottom of the plot, in blue. Genetic-marker positions are determined from the deCODE Genetics sex-averaged map,
and DNPL scores are indicated by red lines. A, Interaction on chromosome 2q22-q24, presented using STRs on 6q as conditional markers
(highest DNPL score 6.69). B, Interaction on chromosome 6q23-q24, presented using STRs on 2q as conditional markers (highest DNPL
score 4.84).
10, only a few families ( –6) contributed to these find-np 1
ings with a weightPROP factor 11. Table 9 provides detailed
information about the permutation results and families
included.
Although none of the regions listed in table 7 was im-
plicated twice as a top 10 finding, four appeared to be of
particular interest when adjacent markers at both sides
were included—the conditional and at the scan locus. All
DNPL scores belonged hereby to the top 100 heterogeneity
findings (see table 8). In detail, the use of negative NPLs
as inversely proportional weight at four adjacent STRs on
11p13-p15 increased the linkage evidence at two neigh-
boring markers on chromosome 6p24-p25 (DNPL scores
12.27) (see table 8), and the strongest heterogeneity evi-
dence was observed at D6S477 (DNPL score of 2.65, het-
erogeneity NPL score of 3.19, rank 1; ) (table 7).Pp .0004
Five neighboring conditional markers at a second locus
on chromosome 11—at 11p12-q13—increased the linkage
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Figure 3. Proportions of families contributing to the BPAD in-
teraction. The legend is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 6. DNPL Scores for the BPAD Interaction between Chromosomes 2q22-q24 and 15q26
Chromosome
and Rank
Conditional Marker Scan Marker
Marker Positiona Marker Positiona
Baseline
NPL
Interaction
NPL DNPL
2q22-q24:
1 STR15-1002 133.69 D2S1399 158.20 .04 5.62 5.62
2 STR15-1002 133.69 D2S381 157.19 .03 5.59 5.59
3 D15S642 133.60 D2S1399 158.20 .04 5.58 5.58
4 D15S642 133.60 D2S381 157.19 .03 5.56 5.56
5 STR15-1002 133.69 D2S222 158.53 .06 5.62 5.56
6 D15S642 133.60 D2S222 158.53 .06 5.58 5.52
7 STR15-1002 133.69 D2S2334 153.41 .63 5.89 5.26
8 D15S642 133.60 D2S2334 153.41 .63 5.86 5.23
9 STR15-1002 133.69 D2S2950 165.18 .88 6.00 5.12
10 D15S642 133.60 D2S2950 165.18 .88 5.96 5.08
15q26:
1 D2S1353 167.91 D15S642 133.60 .11 3.86 3.74
2 D2S1353 167.91 STR15-1002 133.69 .11 3.84 3.73
3 D2S2395 169.58 D15S642 133.60 .11 3.79 3.68
4 D2S2950 165.18 D15S642 133.60 .11 3.78 3.67
5 D2S2395 169.58 STR15-1002 133.69 .11 3.77 3.67
6 D2S2950 165.18 STR15-1002 133.69 .11 3.77 3.66
7 D2S321 163.27 D15S642 133.60 .11 3.52 3.41
8 D2S2241 163.27 D15S642 133.60 .11 3.52 3.41
9 D2S321 163.27 STR15-1002 133.69 .11 3.50 3.40
10 D2S2241 163.27 STR15-1002 133.69 .11 3.50 3.40
NOTE.—The first set of 10 rankings represents the strongest DNPL and interaction NPL scores on chromosome
2q22-q24 with the use of STRs on 15q as conditional markers. The second set of 10 rankings represents the
strongest DNPL and interaction NPL scores on chromosome 15q26 with the use of STRs on 2q as conditional
markers. In addition, for each scan marker, the baseline NPL score is presented.
a Determined from the deCODE Genetics sex-averaged map. No genetic map information is available for markers
D15S107, STR15-980, and STR15-994. For these markers, genetic map positions were calculated by interpolating
their physical positions (according to the UCSC Genome Browser) with the nearest marker listed by the deCODE
Genetics sex-averaged map.
evidence at four adjacent STRs on 9p21-q21 (DNPL scores
12.13) (see table 8), and the best finding was observed
for D9S1122 (DNPL score of 2.56, heterogeneity NPL
score of 2.56, rank 7; ) (table 7). Interestingly,Pp .0001
inversely proportional NPL weights at 13q31 increased the
linkage evidence at 2q22-q24, one of our BPAD-interac-
tion regions. The use of two adjacent conditional markers
on 13q resulted in DNPL scores 12.22 at three neighboring
STRs on 2q22-q24 (see table 8), and the strongest DNPL
score of 2.57 was observed for D2S1399 (heterogeneity
NPL score of 2.94, rank 6; ) (table 7). EvidencePp .0096
of locus heterogeneity was also observed on 8q24. The
linkage findings increased at two adjacent markers on 8q
when two neighboring STRs on chromosome 16q21 were
used as conditional markers (see table 8). The best DNPL
score of 2.59 was found for D8S1128 (heterogeneity NPL
score of 3.00, rank 4; ) (table 7).Pp .0004
Locus Heterogeneity in BPAD-Interaction Regions
We were particularly interested in the pattern of locus
heterogeneity at the identified BPAD-interaction regions.
The strongest evidence of locus heterogeneity was ob-
served at 2q22-q24 with the use of 13q31 conditional
markers (see above). One other finding belonged to the
top 10 results and was supported by adjacent STRs on the
scan side. Using D22S1169 on 22q11 as the conditional
STR produced DNPL scores 12.27 at three markers within
the BPAD 2q21-q22 interval (see table 8). The strongest
result was observed at D2S1334 (DNPL score of 2.55, het-
erogeneity NPL score of 3.29, rank 8; ) (table 7).Pp .0154
Although there was some further evidence of locus het-
erogeneity on 2q when markers on 3q29 and 7q35-q36
were used as conditional markers and on 19q13 with use
of a 2q STR as a conditional marker (table 8), no other
interacting STR—including markers on 6q and 15q—was
highlighted by the top 100 heterogeneity findings or by
the inclusion of heterogeneity results at adjacent markers.
Discussion
BPAD-Interaction Evidence between Chromosomes 2q22-q24
and 6q23-q24
Whereas chromosome 6q23-q24 already showed linkage
evidence within our one-dimensional linkage scan (NPL
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Figure 4. Three-dimensional DNPL plot for the BPAD interaction between chromosome 2q22-q24 and 15q26. The 1-LOD intervals are
given at the bottom of the plot, in blue. Genetic-marker positions are determined from the deCODE Genetics sex-averaged map, and
DNPL scores are indicated by red lines. A, Interaction on chromosome 15q26, presented using STRs on 2q as conditional markers (highest
DNPL score 3.74). B, Interaction on chromosome 2q22-q24, presented using STRs on 15q as conditional markers (highest DNPL score
5.62).
score of 2.67 at D6S1009) (see table 3 and the work of
Schumacher et al.4), chromosome 2q22-q24 showed no
linkage evidence within this study (NPL scores 0.23–1.06)
(see table 3). This BPAD locus was detectable only by the
performance of a two-dimensional linkage scan. With use
of a 1-LOD interval, the underlying BPAD gene on 2q is
located between 150 and 166 cM (fig. 2A), corresponding
to ∼137 and ∼157 Mb, respectively, according to National
Center for Biotechnology Information (NCBI) build 36.1.
Although this region has not been listed among the con-
firmed BPAD-linkage regions so far (as reviewed in the
work of Craddock and Forty2), evidence of a BPAD gene
within this interval comes from independent studies. At
145 Mb, Middleton et al.13 observed the second-best re-
sult—NPL score of 3.09—within their genomewide scan
of 25 multiplex families with BPAD. At 147 Mb (marker
D2S151), Ewald et al.14 found an NPL score of 4.24 in one
multiplex family with BPAD, and Fallin et al.15 reported
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Table 7. Genomewide Top 10 DNPL Scores in BPAD, Ordered according to Regions of Locus Heterogeneity
Rank
Conditional Marker Scan Marker
PbChromosome Marker Positiona Chromosome Marker Positiona
Baseline
NPL
Heterogeneity
NPL DNPL
1 11 D11S1981 25.59 6 D6S477 9.18 .54 3.19 2.65 .0004
2 6 D6S1613 96.90 X DXS7108 18.37 .01 2.60 2.59 !.0001
3 11 D11S912 137.90 3 D3S4545 23.45 .14 2.59 2.59 .0005
4 16 D16S3396 61.64 8 D8S1128 135.57 .41 3.00 2.59 .0004
5 21 D21S2052 29.48 22 D22S689 32.92 .08 2.65 2.57 .0001
6 13 D13S265 80.80 2 D2S1399 152.04 .38 2.94 2.57 .0096
7 11 D11S1279 57.39 9 D9S1122 74.35 .17 2.56 2.56 .0001
8 22 D22S1169 68.82 2 D2S1334 145.08 .75 3.29 2.55 .0154
9 9 D9S910 101.60 1 D1S549 239.66 .79 3.32 2.53 !.0001
10 22 D22S1169 68.82 11 D11S1998 119.99 .08 2.52 2.52 .0001
NOTE.—For each scan marker, the DNPL and the heterogeneity NPL scores are presented. In addition, the baseline NPL score observed in the
one-dimensional genomewide scan is presented.
a Determined from the deCODE Genetics sex-averaged map.
b P values are determined through 10,000 genomewide permutations.
an NPL score of 2.16 in 41 families with BPAD. At 159 Mb
(at D2S1353), Cheng et al.16 observed a 2-point LOD score
of 2.07 in 154 families with BPAD. In addition, the BPAD
genomewide association study by Ophoff et al.17 identified
two adjacent three-STR-marker haplotypes starting at 154
Mb, which were associated in 109 patients.
Furthermore, chromosome 6q23-q24 is implicated as
harboring a BPAD gene by independent studies (reviewed
by Craddock and Forty2). The 1-LOD interval indicates
that the BPAD susceptibility locus is located between 131
and 148 cM on chromosome 6 (fig. 2B), corresponding to
∼132 and ∼147 Mb, respectively, according to NCBI build
36.1. Within this region, Venken et al.18 found their sec-
ond-best linkage result with a multipoint LOD score of
3.25 between 142 and 149 Mb (D6S310 and D6S1654) in
nine multiplex families with BPAD. At 137 Mb (marker
D6S1009), Ewald et al.19 reported a 2-point LOD score of
2.49 in two multiplex families with BPAD, and Rice et al.20
observed a (moderate) 2-point LOD score of 2.08 in 97
families with BPAD. D6S1009 is the conditional marker
that produced the strongest interaction on 2q within our
genomewide scan (DNPL score 6.94 at D2S1399) (table 3).
In addition, the identified region on 6q23-q24 overlaps
with the most significant implicated BPAD locus in the
linkage meta-analysis by McQueen et al.21 They combined
the data sets of 11 individual BPAD-linkage studies and
found genomewide significant linkage evidence on chro-
mosome 6q, with a peak LOD score of 4.19 at 108 Mb.
Collectively, the data provide strong evidence of BPAD
genes between 137 Mb and 157 Mb on chromosome 2
and between 132 Mb and 147 Mb on chromosome 6,
which contribute epistatically to BPAD. According to the
RefSeq Genes track (University of California–Santa Cruz
[UCSC] Genome Browser), the genomic intervals on chro-
mosomes 2q and 6q contain 32 and 70 known genes,
respectively. Although speculative, there are some genes
within both regions that act through the same or related
pathways. For example, several genes involved in inflam-
matory processes are located on 2q22-q24 (TNFAIP6
[MIM 600410] and NMI [MIM 603525]) and on 6q23-q24
(TNFAIP3 [MIM 191163], IL20RA [MIM 605620], IL22RA2
[MIM 606648], and IFNGR1 [MIM 107470]). These genes
are interesting, since some studies point to an inflam-
matory pathomechanism in BPAD (reviewed in the work
of Liu et al.,22 Kaufman,23 and O’Brien et al.24). In addition,
lithium, the medication of first choice for the long-term
treatment of BPAD, is known to have inflammation-mod-
ulating effects (see the work of Maes et al.,25 Bournat et
al.,26 and Nemeth et al.27). However, systematic SNP-based
linkage disequilibrium (LD) mapping should lead to the
identification of the BPAD genes within both regions. The
consideration of the underlying epistasis and the appli-
cation of conditional LD studies may be crucial for the
successful positional cloning of these genes.
BPAD-Interaction Evidence between Chromosomes 2q22-q24
and 15q26
Similar to chromosome 2q22-q24, which has not been
listed among the confirmed BPAD-linkage regions so far
(see above), chromosome 15q26 has attracted less atten-
tion in BPAD. This may reflect the limited power of one-
dimensional linkage scans to detect loci that act through
epistasis. However, four independent studies that used
samples from families affected with BPAD or combined
BPAD and schizophrenia reported linkage evidence within
the 15q26 interaction region. Defined by the 1-LOD cri-
terion, the present results indicate that the interesting 15q
interval is located between 118 cM and the telomere
(∼133.7 cM) (fig. 4B), corresponding to 95 Mb and 100.3
Mb, respectively, according to NCBI build 36.1. Within
this region, Maziade et al.28 observed a maximized LOD
score of 4.55 at 96 Mb (at D15S1014) in 21 multiplex
families affected by BPAD and/or schizophrenia. Using the
same phenotype definition, Vazza et al.29 found an NPL
score of 3.05 in 16 families with BPAD or schizophrenia
at the same marker (D15S1014). At D15S642, which was
the strongest implicated 15q marker in our interaction
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Table 8. Top 100 Genomewide
Heterogeneity DNPL Scores in BPAD,
Ordered according to the Conditional
Chromosomes
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 9. Permutation Analysis of the Top 10 Locus-Heterogeneity DNPL Scores
Conditional Locus Scan Locusa Permutation Analysisb
Marker
No. of Families
with Weightc
10, 11 Marker
Baseline
NPL
Heterogeneity
NPL
Heterogeneity NPL
Exceeded (P)
Average
NPLd
Min.
NPLe
Max.
NPLe SDf
D11S1981 24, 1 D6S477 .5441 3.1911 4 (.0004) .279 2.2587 3.6576 .8239
D6S1613 36, 6 DXS7108 .0076 2.5962 0 (!.0001) .0026 2.1758 2.2011 .6125
D11S912 34, 5 D3S4545 .1400 2.5872 5 (.0005) .0945 2.4013 3.1298 .7696
D16S3396 33, 3 D8S1128 .4134 2.9987 4 (.0004) .2493 2.2675 3.2651 .8035
D21S2052 26, 3 D22S689 .0809 2.6527 1 (.0001) .0538 1.9114 2.9359 .6929
D13S265 33, 3 D2S1399 .3762 2.9446 96 (.0096) .2359 2.5743 4.2921 1.0330
D11S1279 28, 1 D9S1122 .1708 2.5562 1 (.0001) .1065 2.4815 2.6951 .7140
D22S1169 31, 1 D2S1334 .7477 3.2931 154 (.0154) .4218 2.1720 5.4990 .0831
D9S910 36, 4 D1S549 .7892 3.3150 0 (!.0001) .5184 1.7529 3.1184 .7245
D22S1169 31, 1 D11S1998 .0844 2.5228 1 (.0001) .0574 2.2374 2.6153 .6446
a Results of the heterogeneity analysis obtained at the scan locus.
b Results of the permutation analysis.
c Number of families included in the heterogeneity analysis, with use of weightPROP factors 10 and weightPROP factors 11.
d Average NPL score observed from the permutation procedure.
e Minimal (Min.) and maximal (Max.) NPL score observed from the permutation procedure.
f SD from the average NPL.
scan, Park et al.30 observed a 2-point LOD score of 1.96 in
40 families with BPAD. D15S642 (at 100 Mb) also belongs
to one of the 21 markers that showed significant LD in
the genomewide BPAD-association study by Ophoff et al.17
In addition, 15q26 is implicated in major depressive dis-
order (MDD). Holmans et al.31 reported a multipoint LOD
score of 3.73 at D15S652 (at 90 Mb) in their first-phase
MDD sample of 297 families and confirmed this finding
with a multipoint Z likelihood-ratio score of 3.05 between
90 Mb and 93 Mb in their full MDD sample of 656 families
with MDD.32
However, since only a moderate proportion of families
contributed to our interaction evidence on 2q and 15q
and since the observed epistasis between both loci ap-
peared to be less impressive than the interaction seen for
2q and 6q, our 2q-15q BPAD interaction finding should
be interpreted more carefully and requires confirmation.
It therefore seems premature to discuss whether our in-
teraction findings between 2q22-q24 and 6q23-q24 and
between 2q22-q24 and 15q26 point to a multidimen-
sional epistasis involving all three loci. However, in our
genomewide scan, we observe a DNPL score of 4.53 at
D6S1009, using D15S642 as a conditional marker (rank
15) and a DNPL score of 4.39 in the vice-versa direction
(rank 20) (table 2), which may support the idea of a higher-
dimensional epistasis.
Independent Interaction Linkage Studies in BPAD
Two studies that apply interaction linkage analysis to
BPAD have been previously published; both used prese-
lected markers. McInnis et al.33 selected five conditional
STRs that showed NPL scores between 2.2 and 3.3 in
their baseline linkage scan and performed an interaction
analysis with 153 families with BPAD-affected sib pairs.
They observed linkage increases (DNPLs) in the range
1.7–2.7 (interaction NPL scores between 2.3 and 3.1) at
five different marker combinations. None of these find-
ings showed DNPL scores2 within our genomewide scan
(data not shown), which, together with the level of their
interaction evidence, may indicate that their results rep-
resent more-moderate epistatic effects. Furthermore, the
families in the study of McInnis et al.33 were assigned using
the weight1-0 method, whereas we applied the weightPROP
method of Cox et al.10 In construction of the weight1-0
family weighting, families are assigned weight 0 if their
NPL score at the conditional locus is 0 and weight 1 if
their NPL score is 10. In contrast, within the weightPROP
method, more-complex family-specific weights propor-
tional to the evidence of linkage at the conditional locus
are used, and it has been shown that both weighting meth-
ods can lead to different results.10 The second BPAD-in-
teraction study analyzed 18 preselected markers across
chromosome 6 in 245 families with affected sib pairs and
pointed to an epistatic effect between 6p22 and 6q16-
q21.34 Our study design was restricted to the analysis of
interchromosomal epistasis only. Although this repre-
sents a limitation of our study, we used this design to
avoid false-positive results by analyzing STRs, which are
on the same chromosome and may therefore segregate
dependently.
Locus Heterogeneity in BPAD
Compared with our BPAD-interaction findings, the locus-
heterogeneity analysis produced a less consistent picture.
Although several of the DNPL scores were significant by
permutation, inspection of the family-specific data re-
984 The American Journal of Human Genetics Volume 81 November 2007 www.ajhg.org
vealed that each of these results was attributable to a small
number of families (between 1 and 6 families each). There-
fore, these results should be viewed with caution and need
further confirmation. However, our findings on chromo-
somes 2q, 6p, 13q, and 22q showed a more congruent
picture of locus heterogeneity, and they have been pro-
posed to harbor BPAD risk genes by independent studies.
For example, BDNF (MIM 113505), one of the most im-
plicated candidate genes in BPAD (as reviewed in the
work of Craddock and Forty2), is located in our hetero-
geneity region on 11p13-p15. Furthermore, our STRs on
6p24-p25 represent the closest genomewide scan markers
to DTNBP1 (MIM 607145), which also has attracted at-
tention in BPAD.35–38 Although speculative, our results
may provide evidence that families with BPAD who share
no BDNF risk variants at 11p are more susceptible to BPAD
risk variants at 6p or DTNBP1. In addition, chromosomal
regions 13q31 and 22q13 were both highlighted by one
of the linkage meta-analyses applied to BPAD so far39 and
by individual linkage studies. Detera-Wadleigh et al.40 and
Kelsoe et al.41 observed strong BPAD-linkage evidence on
13q and 22q, which overlap with our findings on both
chromosomes. Furthermore, BPAD-linkage evidence on
chromosome 13q was reported by Shaw et al.42 Thus, the
present study provides evidence that families who share
no BPAD risk genes at the linkage loci 13q and 22q could
be more susceptible to BPAD risk genes on 2q22-q24,
which represents a BPAD-linkage region as well (see
above). Convincing linkage evidence has been indepen-
dently reported for some of the other BPAD heterogeneity
regions—for example, for chromosome 8q24 (as reviewed
in the work of Craddock and Forty2). However, the cor-
responding conditional or scan regions have not attracted
attention to BPAD so far. Although this does not neces-
sarily exclude them as heterogeneity loci, the probability
for a true-positive finding might be higher when inde-
pendent studies have already reported BPAD linkage at
both sides—the conditional and the scan region.
Conclusions and Outlook
Our study represents the first systematic genomewide
interaction and locus-heterogeneity analysis applied to
BPAD. With use of this approach, chromosome 2q22-q24,
which showed no linkage evidence in our one-dimen-
sional linkage scan, has been strongly implicated as har-
boring a BPAD gene, which interacts epistatically with a
second risk locus on 6q23-q24. Although multidimen-
sional linkage scans involve multiple testing, making it
crucial to control the overall type I error (e.g., see the work
of Frankel and Schork43), we suppose that the 2q-6q in-
teraction represents a true-positive finding. This is impli-
cated by the strength of interaction evidence (NPL scores
7.55 on 2q and 7.63 on 6q), the results through 10,000
permutations ( and , respectively), andP ! .0001 Pp .0001
the fact that a high proportion of our families contribute
to this interaction. In addition, both loci have been im-
plicated independently in BPAD, and it seems rather un-
likely to find by chance evidence of a BPAD epistasis be-
tween both regions when applying a systematic inter-
action approach.
Several studies propose that the consideration of gene-
gene interaction at the association level offers great po-
tential in the identification of risk genes for complex dis-
orders (e.g., the work of Carlson et al.44 and Lin et al.45).
However, in the absence of established risk genes, only
hypothesis-free genomewide interaction linkage data can
provide systematic insights into the framework of epis-
tasis. This is the strength of interaction linkage scans,
which could be of importance in forthcoming genome-
wide association studies. The loci identified through in-
teraction linkage scans should lead to more-comprehen-
sive strategies in the analysis of genomewide LD data, and
the application of conditional LD analyses may facilitate
the identification of the underlying risk and interacting
genes.
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